Use of lectins as diagnostic and therapeutic tools for cancer

Journal of Pharmacological and Toxicological Methods

Volumn 33, Issue 1, 1995, Pages 1-10

  Mody, Rustom ^a   Joshi, S H antaram ^b   Chaney, William ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cancer; Diagnosis; Glycoconjugates; Lectins; Metastasis; Therapy

Indexed keywords

ABRIN; AGGLUTININ; ANTINEOPLASTIC AGENT; BIOLOGICAL RESPONSE MODIFIER; CONCANAVALIN A; GLYCOCONJUGATE; IMMUNOTOXIN; LECTIN; LEUKOAGGLUTININ; WHEAT GERM AGGLUTININ;

CANCER; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CYTOTOXICITY; HUMAN; METASTASIS; NONHUMAN; REVIEW;

ANIMAL; HUMAN; LECTINS; NEOPLASMS;

EID: 0028872958     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8719(94)00052-6     Document Type: Review

References (169)

1. Immunocytochemical staining of cells in 153 pleural effusions with a panel of monoclonal antibodies and lectins
2. Galaptin and galaptin-binding glycoconjugates in serum and effusion of carcinoma patients
3. Sulfated polysaccharides in inflammation
4. Granule membrane protein 140 (GMP 140) binds to carcinomas and carcinoma-derived cell lines
5. Carbohydrate specific receptors of the liver
6. Tumor growth and adherence change the expression of macrophage Mac-2
7. Antitumoral effects of Pseudomonas aeruginosa lectins on Lewis lung carcinoma cells cultured in vitro without and with murine splenocytes
8. Soluble lectins: A new class of extracellular proteins
9. Multiple soluble vertebrate galactoside-binding lectins
10. Behaviour of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients
11. Influence of treatment with the immunomodulatory effective dose of the β-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c- mice for two experimental model systems
12. Conformation of methyl B-lactoside bound to ricin B-Chain: Interpretation of transferred nuclear Overhauser effects facilitated by spin simulation and selective deuteration
13. Mistletoe (Viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy
14. Use of the lectin from Amaranthus caudatus as a histochemical probe of proliferating colonic epithelial cells
15. Effect of cancer-related and drug-induced alterations in surface carbohydrates on the invasive capacity of mouse and rat cells
16. Drug targeting Synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugate
17. Affinity electrophoresis for diagnosis of cancer and inflammatory conditions
18. Markers of prognosis in breast cancer: The relationship between binding of the lectin HPA and histological grade, SPF, and ploidy
19. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. II. Chemotherapy of Gardner lymphosarcoma with pea seed lectin-methotrexate derivative
20. Use of lectin histochemistry in pancreatic cancer
21. Tenascin and other adhesion-modulating proteins in cancer
22. Alpha-fetoprotein as tumor marker in lung cancer diagnosis
23. Binding and endocytosis of glycoproteins and neoglycoproteins by isolated rabbit hepatocytes
24. Peanut lectin-binding sites in large bowel carcinoma
25. Rapid phosphorylation and selective dephosphorylation of P-selectin accompanies platelet activation
26. Characterization of the structural determinants required for the high affinity interaction of asparaginelinked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erytroagglutinating lectins
27. Lectin cytochemistry and histochemistry
28. Lectin binding sites on the luminal surface of ependymal cells of the rat spinal cord
29. Monoclonal antibodies and tumor associated antigens
30. Endothelial leukocyte adhesion molecule-1-dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type I carbohydrate chain
31. Tumor cell surface carbohydrates and the metastatic phenotype
32. Changes in glycosylation associated with malignant transformation and tumor progression
33. Asparagine-linked oligosaccharides associated with metastatic cancer
34. Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon, and prostate: A blind trial with 420 patients
35. A comparative study of histopathology, hormone receptors, peanut lectin binding, Ki-67 immunostaining, and nucleolar organizer regionassociated proteins in human breast cancer
36. Two distinct classes of carbohydrate-recognition domains in animal lectins
37. Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma: Diagnostic utility at low serum levels
38. Subcellular localization of blood group A substance produced by pancreatic adenocarcinoma induced in hamsters by N-nitrosobis(2-oxopropyl)amine (BOP) and by its cell line (PC-1)
39. Cell adhesion and metastasis
40. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens
41. Mucin glycoproteins as tumor markets
42. Endogenous lectins in tumors and the immune system
43. Targeting of neoglycoprotein-drug conjugates to human tumor cells via endogenous lectins
44. Tumor lectinology At the intersection of carbohydrate chemistry biochemistry cell biology and oncology
45. Detection and functions of mammalian lectins—with emphasis on membrane lectins
46. Differential expression of endogenous sugar-binding proteins (lectins) in murine tumor systems with metastatic capacity
47. Targeting of neoglycoprotein-drug conjugates to cultured human embryonal carcinoma cells
48. Differences in the pattern of endogenous lectins from spontaneous rat mammary tumors
49. Detection of tumor-associated expression of carbohydrate-binding proteins (lectins): The use of neoglycoproteins and neoglycoenzymes in glycohistochemical and glycocytological studies
50. From ill-defined extracts to the immunomodulatory lectin: Will there be a reason for oncological application of mistletoe?
51. Heparin-binding lectin of human placenta as a tool for histochemical ligand localization and isolation
52. Carbohydrate-binding proteins of tumor lines with different growth properties: II. Changes in their pattern in colons of transformed rat fibroblasts of differing metastatic potential
53. The immunomodulatory galactoside-specific lectin from mistletoe: Partial sequence analysis, cell and tissue binding, and impact on intracellular biosignalling of monocytic leukemia cells
54. Analysis of cell surface sugar receptor expression by neoglycoenzyme binding and adhesion to plastic-immobilized neoglycoproteins for related weakly and strongly metastatic cell lines of murine tumor model systems
55. Effects of Pseudomonas aeruginosa PA-I and PA-II lectins on tumoral cells
56. Isolation physicochemical characterization, and carbohydrate-binding specificity of lectins
57. Characterization of oligosaccharides by lectin affinity high-performance liquid chromatography
58. Expression of adhesion molecules in lymphoproliferative disorders
59. Expression of selectin ligands by cutaneous squamous cell carcinoma
60. Increased secretion of tumor necrosis factor-α, interleukin-1 and interleukin-6 by human mononuclear cells exposed to β-galactoside specific lectin from clinically applied mistletoe extract
61. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens
62. Growth behaviour, contact, and cell surface structure of cells
63. Mitogenic leukoaggultinin from Phaseolus vulgaris binds to a pentosaccharide unit in N-acetyllactosamine type glycoprotein glycans
64. Plant lectins: Histochemical and cytochemical applications in oncology
65. Lectin affinity electrophoresis of alpha-fetoprotein: Increased specificity and sensitivity as a marker of hepatocellular carcinoma
66. Observation on tumor seeking agents for cancer diagnosis and therapy
67. Radiolabelled peanut lectin for the scintigraphic detection of cancer
68. Lectins as cell adhesion molecules
69. Glycoconjugates and tumor metastasis
70. Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein levels: A case report and a review of 28 cases reported in Japan
71. Cell adhesion molecules in neoplastic disease
72. Determination of lectin-mediated augmentation of natural killer cell-mediated cytotoxicity
73. Immunotherapeutic effects of purified mistletoe lectin, ML-I, on murine large cell lymphoma
74. Cell surface properties associated with malignancy of metastatic large cell lymphoma cell line
75. Galactoside specific VAA lectin-induced apoptosis in human leukemia cells
76. Adhesion molecules in cancer: The role of integrins
77. Low-dose chymotrypsin treatment inhibits neutrophil migration into sites of inflammation in vivo: Effects on Mac-1 and MEL-14 adhesion protein expression and function
78. Expression of lectin-specific cellular glycoconjugates during oral carcinogenesis
79. Glycobiology: A growing field for drug design
80. Alpha-fetoprotein-producing pancreatic cancer: A case report and review of 28 cases
81. Histomorphological characterization of carbohydrate-binding proteins in human lung cancer
82. Lectin-carbohydrate interactions in immunoregulation
83. Biodistribution of radioactive lectins
84. Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blocking O-glycosylation of these cells
85. Applications of lectins to tumor imaging radiopharmaceuticals
86. Glycoprotein-lectin-immunosorbent assay
87. Modified porphyrins, chlorins, phthalocyanines, and purpurins: Second generation photosensitizers for photodynamic therapy
88. Colonic oligosaccharide structures deduced from lectin-binding studies before and after desialytion
89. Lectin cell adhesion molecules (LEC-CAMs): A new family of cell adhesion proteins involved with inflammation
90. Sulfatides trigger increase of cytosolic free calcium and enhanced expression of tumor necrosis factor-alpha and interleukin-8 mRNA in human neutrophils: Evidence for a role of L-selectin as a signaling molecule
91. Tumor cell adhesion to endothelial cells: Endothelial leukocyte adhesion molecule-1 as an inducible adhesion receptor spectific for colon carcinoma cells
92. Neoglycoconjugates: Fundamentals and recent progress
93. Utica dioca agglutinin, a new mitogen for murine T-lyphocytes: Unaltered IL-1 production but late IL-2 mediated proliferation
94. The gene for stinging nettle lectin (Utica dioica agglutinin) encodes both a lectin and a chitinase
95. Inflammatory roles of P-selectin
96. Ribosome inactivating proteins of plants
97. Biochemical and immunological characterization of K-1735P melanoma galactoside-binding lectins and their modulation by differentiation inducers
98. Modulation of galactoside-binding lectins in tumor cells by differentiation-inducing agents
99. Inhibition of tumor cell colony formation in culture by a monoclonal antibody to endogenous lectins
100. Lactose-binding lectin expression in human colorectal carcinomas: Relation to tumor progression
101. Lectins in cancer cells
102. Induction of N-acetylglucosaminyltransferase V by elevated expression of activated or proto-Ha-ras oncogenes
103. Tumor cell surface beta 1–6 branched oligosaccharides and lung metastasis
104. Protein-carbohydrate complementarity in mammalian gamete recognition
105. Tumor markers
106. Recombinant E-selectin-protein mediates tumor cell adhesion via sialy-Lea and Sialyl-Lex
107. Carbohydrate profiles shown by a lectin and a monoclonal antibody correlates with metastatic potential and prognosis of human lung carcinoma
108. Binding pattern of eight different lectins in healthy subjects and patients with dysplastic and malignant lesions of the oral cavity
109. Adhesive interactions in angiogenesis and metastasis
110. The application of lectins to the characterization and isolation of mammalian cell populations
111. Lectin affinity chromatography of glycopeptides
112. Carbohydrates and fertilization in animals
113. Membrane glycoproteins, glycolipids and membrane lectins as recognition signals in normal and malignant cells
114. Endogenous lectins and drug targeting
115. Evidence that recombinant IL-Iα exhibits lectin-like specificity and binds to homogenous uromodulin via N-linked oligosaccharide
116. Neutrophil-dependent acute lung injury: Requirement for P-selectin (GMP-140)
117. Lectin binding and expression of blood group-related antigens in carcinoma-in-situ and invasive carcinoma of urinary bladder
118. Cell surface molecules and tumor metastasis
119. Tumor and host molecules important in the organ preference of metastasis
120. Enhanced interaction of L-selectins with high endothelial venule ligand via selectively oxidized sialic acids
121. Primary lung cancer producing alpha-fetoprotein
122. Induction of release of cytotoxin from murine bone marrow cells by an animal lectin
123. Alpha-fetoprotein (AFP)-producing gastric carcinoma: Is it hepatoid differentiation?
124. The activity of two immunotoxins composed of monoclonal antibody MoAb-16 and A-chain of ricin (MoAb-16-RTA) or A-chain of mistletoe lectin I (MoAb-16-MLIA)
125. Rapid detection of proteins by enzyme-linked immunofiltration assay after transfer onto nitrocellulose membranes
126. Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia
127. Tumor progression in vivo: Increased soybean agglutinin lectin binding, N-acetylgalactosamine-specific lectin expression, and liver metastasis potential
128. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion
129. Potential role of cell surface lectins in lymphocyte recirculation
130. Prokaryotic peptides that block leukocyte adherence to selectins
131. Distribution of colon cancer cells permanently labelled by lectin-mediated endocytosis of a trap label
132. Peanut lectin: A mitogen for normal human epithelium and human HT29 colorectal cancer cells
133. Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials
134. Phenotypic changes in tumor vessels associated with the progression of hepatocellular carcinoma
135. Ovarian and hepatic metastases of gastric carcinoma associated with high serum levels of human chorionic gonandrotropin (hCG), alpha-fetoprotein (AFP), and carcinoembryonic antigen (CEA): A case report
136. Sialic acids as regulators of molecular and cellular interactions
137. Binding of mitogenic plant lectins to human lymphocytes: Flow cytometric analysis
138. Macromolecule-drug conjugates in targeted cancer chemotherapy
139. Lectins as cell recognition molecules
140. Carbohydrates in cell recognition
141. The lectin-like interaction between recombinant tumor necrosis factor and uromodulin
142. IL-2, a lectin with specificity for high mannose glycopeptides
143. Establishment of assay kits for determination of microhetrogenities of alpha-fetoprotein using lectin-affinity electrophoresis
144. Study of oligosaccharidelectin interaction by nuclear magnetic resonance (NMR) techniques and computational methods
145. Lectin and neoglycoprotein binding to cells
146. Fertilization: A model for cell-cell interaction
147. Extent of desialation of blood group MM, NN, and MN antigens required for reactivity with human anti-T antibody and Arachis hypogaea lectin
148. Adhesion of human cancer cells to vascular endothelium mediated by carbohydrate antigen, sialyl Lewis A
149. Cadherins in cancer: Implications for invasion and metastasis
150. A collaborative study for the evaluation of lectin-reactive alpha-fetoprotein in early detection of hepatocellular carcinoma
151. Modulation of lectin-triggered superoxide release from neutrophiles of tumor patients with and without chemotherapy
152. Immunotoxin with mistletoe lectin I A-chain and ricin A-chain directed against CD5 antigen of human T-lymphocytes: Comparison of efficiency and specificity
153. Tumor induction with the N'acetyl derivative of 4-hydroxymethyl-phenylhydrazine, a metabolite of agaritine of Agaricus bisporus
154. Quantitative microscopy of mouse colon 26 cells growing in different metastatic sites
155. The use of lectins in histopathology
156. Assessment of milk fat globule membrane antibodies and lectins as markers of short-term prognosis in breast cancer
157. x determinant on myeloid and tumor cells
158. Neutrophil influx into an inflammatory site inhibited by a soluble homing receptor-IgG chimera
159. Role of lectins in immune regulation
160. Characteristics of PHA-L4, the mitogenic isolectin of phytohaeamagglutinin, as an ideal biologic response modifier
161. Therapeutic activities of PHA-L4, the mitogenic isolectin of phytohaemagglutinin
162. The rationale of mitogenic lectin therapy for cancer
163. Serum alpha-fetoprotein and its lectin reactivity in liver diseases: A review
164. Over expression of a β-galactoside binding protein causes transformation of BALB3T3 fibroblast cells
165. Molecular basis of tumor progression: Mechanism of organ-specific tumor metastasis
166. Cell surface glycolipids and glycoproteins in malignant transformation
167. Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin
168. Adhesion molecules in tumor metastasis